Abstract
Most persons experience cognitive decline as they grow older. The term “cognitive aging,” coined to describe milder varieties of cognitive decline, is likely to be due to multiple causes. Persistent or repeated infections of the central nervous system (whether subclinical or diagnosable) can cause damage to neurons directly or indirectly through inflammation resulting in incremental neuronal damage, thus eroding cognitive reserve. This possibility has not been considered widely. We evaluated the data linking persistent infection with herpes simplex virus type 1 (HSV-1) and cognitive aging by applying the Bradford Hill criteria. Despite inherent problems in establishing causal relations for chronic disorders, our analyses suggest plausible links. These studies are pertinent for patients with schizophrenia, who are particularly vulnerable due to disorder-related cognitive impairment. Further investigations are warranted to test a causal hypothesis, particularly prospective studies and intervention studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group (1998) N Engl J Med 339(5):300–306
Aiello AE, Haan M, Blythe L, Moore K, Gonzalez JM, Jagust W (2006) The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc 54(7):1046–1054
Aiello AE, Haan MN, Pierce CM, Simanek AM, Liang J (2008) Persistent infection, inflammation, and functional impairment in older Latinos. J Gerontol A Biol Sci Med Sci 63(6):610–618
Baringer JR, Pisani P (1994) Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann Neurol 36(6):823–829
Barnes LL, Capuano AW, Aiello AE, Turner AD, Yolken RH, Torrey EF, Bennett DA (2014) Cytomegalovirus infection and risk of alzheimer disease in older black and white individuals. J Infect Dis 211(2):230–237
Barrientos RM, Frank MG, Watkins LR, Maier SF (2012) Aging-related changes in neuroimmune-endocrine function: implications for hippocampal-dependent cognition. Horm Behav 62(3):219–227
Becker Y (2002) Herpes simplex virus evolved to use the human defense mechanisms to establish a lifelong infection in neurons – a review and hypothesis. Virus Genes 24(2):187–196
Bhatia T, Wood J, Iyenger S, Narayanan S, Prasad KM, Chen K, Gur RE, Gur RC, Nimgaonkar VL, Deshpande SN (2016) Dysfunctional emotion discrimination in schizophrenia is associated with HSV-1 infection and improves with antiviral treatment. 55th annual meeting of American College of Neuropsychiatry, American College of Neuropsychiatry, Hollywood, FL
Bhatia T, Wood J, Iyengar S, Narayanan SS, Beniwal RP, Prasad KM, Chen K, Yolken RH, Dickerson F, Gur RC, Gur RE, Deshpande SN, Nimgaonkar VL (2017) Emotion discrimination in humans: its association with HSV-1 infection and its improvement with antiviral treatment. Schizophr Res 193:161–167
Bucks RS, Gidron Y, Harris P, Teeling J, Wesnes KA, Perry VH (2008) Selective effects of upper respiratory tract infection on cognition, mood and emotion processing: a prospective study. Brain Behav Immun 22(3):399–407
Carbone I, Lazzarotto T, Ianni M, Porcellini E, Forti P, Masliah E, Gabrielli L, Licastro F (2014) Herpes virus in Alzheimer’s disease: relation to progression of the disease. Neurobiol Aging 35(1):122–129
Corstjens PL, Abrams WR, Malamud D (2012) Detecting viruses by using salivary diagnostics. J Am Dent Assoc 143(Suppl 10):12S–18S
DeLisi LE, Goldin LR, Nurnberger JI, Simmons-Alling S, Hamovit J, Dingman CW (1987) Failure to alleviate symptoms of schizophrenia with the novel use of an antiviral agent, acyclovir (Zovirax). Biol Psychiatry 22(2):216–220
DeVaughn S, Müller-Oehring EM, Markey B, Brontë-Stewart HM, Schulte T (2015) Aging with HIV-1 infection: motor functions, cognition, and attention – a comparison with Parkinson’s disease. Neuropsychol Rev 25(4):424–438
Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Ruslanova I, Yolken RH (2003a) Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch Gen Psychiatry 60(5):466–472
Dickerson FB, Boronow JJ, Stallings CR, Origoni AE, Yolken RH (2003b) Reduction of symptoms by valacyclovir in cytomegalovirus-seropositive individuals with schizophrenia. Am J Psychiatry 160(12):2234–2236
Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Cole S, Krivogorsky B, Yolken RH (2004) Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biol Psychiatry 55(6):588–593
Dickerson FB, Stallings CR, Boronow JJ, Origoni AE, Sullens A, Yolken RH (2009) Double blind trial of adjunctive valacyclovir in individuals with schizophrenia who are seropositive for cytomegalovirus. Schizophr Res 107(2-3):147–149
Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R (2012) Additive effects of elevated C-reactive protein and exposure to herpes simplex virus type 1 on cognitive impairment in individuals with schizophrenia. Schizophr Res 134(1):83–88
Dickerson F, Stallings C, Origoni A, Katsafanas E, Schweinfurth LA, Savage CL, Yolken R (2014) Association between cytomegalovirus antibody levels and cognitive functioning in non-elderly adults. PLoS One 9(5):e95510
Evans AS (1976) Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med 49(2):175–195
Farooq AV, Shukla D (2012) Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol 57(5):448–462
Fedak KM, Bernal A, Capshaw ZA, Gross S (2015) Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology. Emerg Themes Epidemiol 12:14
Fruchter E, Goldberg S, Fenchel D, Grotto I, Ginat K, Weiser M (2015) The impact of Herpes simplex virus type 1 on cognitive impairments in young, healthy individuals – a historical prospective study. Schizophr Res 168(1–2):292–296
Gerber SI, Krienke UJ, Biedermann NC, Grunze H, Yolken RH, Dittmann S, Langosch JM (2012) Impaired functioning in euthymic patients with bipolar disorder – HSV-1 as a predictor. Prog Neuropsychopharmacol Biol Psychiatry 36(1):110–116
Gould TD, Gottesman II (2006) Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav 5(2):113–119
Gur RE, Nimgaonkar VL, Almasy L, Calkins ME, Ragland JD, Pogue-Geile MF, Kanes S, Blangero J, Gur RC (2007) Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. Am J Psychiatry 164:813–819
Hamdani N, Daban-Huard C, Godin O, Laouamri H, Jamain S, Attiba D, Delavest M, Lépine JP, Le Corvoisier P, Houenou J, Richard JR, Yolken RH, Krishnamoorthy R, Tamouza R, Leboyer M, Dickerson FB (2017) Effects of cumulative herpesviridae and Toxoplasma gondii infections on cognitive function in healthy, bipolar, and schizophrenia subjects. J Clin Psychiatry 78(1):e18–e27
Harkness JM, Kader M, DeLuca NA (2014) Transcription of the herpes simplex virus 1 genome during productive and quiescent infection of neuronal and nonneuronal cells. J Virol 88(12):6847–6861
Hill A (1965) The environment and disease: association or causation? Proc R Soc Med 58:295–300
Hill JM, Ball MJ, Neumann DM, Azcuy AM, Bhattacharjee PS, Bouhanik S, Clement C, Lukiw WJ, Foster TP, Kumar M, Kaufman HE, Thompson HW (2008) The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. J Virol 82(16):8230–8234
Hokkanen L, Launes J (1997) Cognitive recovery instead of decline after acute encephalitis: a prospective follow up study. J Neurol Neurosurg Psychiatry 63(2):222–227
Hokkanen L, Launes J (2007) Neuropsychological sequelae of acute-onset sporadic viral encephalitis. Neuropsychol Rehabil 17(4-5):450–477
Institute of Medicine (2015) Cognitive aging: progress in understanding and opportunities for action. The National Academies Press, Washington
Jonker I, Klein HC, Duivis HE, Yolken RH, Rosmalen JG, Schoevers RA (2014) Association between exposure to HSV1 and cognitive functioning in a general population of adolescents. The TRAILS study. PLoS One 9(7):e101549
Karatas H, Gurer G, Pinar A, Soylemezoglu F, Tezel GG, Hascelik G, Akalan N, Tuncer S, Ciger A, Saygi S (2008) Investigation of HSV-1, HSV-2, CMV, HHV-6 and HHV-8 DNA by real-time PCR in surgical resection materials of epilepsy patients with mesial temporal lobe sclerosis. J Neurol Sci 264(1–2):151–156
Katan M, Moon YP, Paik MC, Sacco RL, Wright CB, Elkind MS (2013) Infectious burden and cognitive function: the Northern Manhattan Study. Neurology 80(13):1209–1215
Kimberlin D, Whitley R (2007) Antiviral therapy of HSV-1 and -2. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (eds) Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge
Kriebs JM (2008) Understanding herpes simplex virus: transmission, diagnosis, and considerations in pregnancy management. J Midwifery Womens Health 53(3):202–208
Liesegang TJ, Melton LJ, Daly PJ, Ilstrup DM (1989) Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 107(8):1155–1159
Lin PJ, Neumann PJ (2013) The economics of mild cognitive impairment. Alzheimers Dement 9(1):58–62
Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, Newman LM (2015) Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One 10(10):e0140765
Miserocchi E, Modorati G, Galli L, Rama P (2007) Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. Am J Ophthalmol 144(4):547–551
Nimgaonkar VL, Yolken RH, Wang T, Chang CC, McClain L, McDade E, Snitz BE, Ganguli M (2016) Temporal cognitive decline associated with exposure to infectious agents in a population-based, aging cohort. Alzheimer Dis Assoc Disord 30(3):216–222
Pandurangi AK, Pelonero AL, Nadel L, Calabrese VP (1994) Brain structure changes in schizophrenics with high serum titers of antibodies to herpes virus. Schizophr Res 11(3):245–250
Paradise M, McCade D, Hickie IB, Diamond K, Lewis SJ, Naismith SL (2015) Caregiver burden in mild cognitive impairment. Aging Ment Health 19(1):72–78
Prasad KM, Shirts BH, Yolken RH, Keshavan MS, Nimgaonkar VL (2007) Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia. Mol Psychiatry 12(1):105–13, 1
Prasad KM, Eack SM, Goradia D, Pancholi KM, Keshavan MS, Yolken RH, Nimgaonkar VL (2011) Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. Am J Psychiatry 168(8):822–830
Prasad KM, Eack SM, Keshavan MS, Yolken RH, Iyengar S, Nimgaonkar VL (2012a) Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial. Schizophr Bull 39(4):857–66
Prasad KM, Watson AM, Dickerson FB, Yolken RH, Nimgaonkar VL (2012b) Exposure to Herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia. Schizophr Bull 38(6):1137–1148
Rowe AM, St Leger AJ, Jeon S, Dhaliwal DK, Knickelbein JE, Hendricks RL (2013) Herpes keratitis. Prog Retin Eye Res 32:88–101
Schretlen DJ, Vannorsdall TD, Winicki JM, Mushtaq Y, Hikida T, Sawa A, Yolken RH, Dickerson FB, Cascella NG (2010) Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia. Schizophr Res 118(1-3):224–231
Shimomura Y, Higaki S (2011) The kinetics of herpes virus on the ocular surface and suppression of its reactivation. Cornea 30(Suppl 1):S3–S7
Shirts BH, Prasad KM, Pogue-Geile MF, Dickerson F, Yolken RH, Nimgaonkar VL (2008) Antibodies to cytomegalovirus and Herpes simplex virus 1 associated with cognitive function in schizophrenia. Schizophr Res 106(2-3):268–274
Smith JS, Robinson NJ (2002) Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 186(Suppl 1):S3–S28
Springate B, Tremont G (2013) Caregiver burden and depression in mild cognitive impairment. J Appl Gerontol 32(6):765–775
Steiner I, Kennedy PG, Pachner AR (2007) The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 6(11):1015–1028
Strandberg TE, Pitkala KH, Linnavuori KH, Tilvis RS (2003) Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke 34(9):2126–2131
Tarter KD, Simanek AM, Dowd JB, Aiello AE (2014) Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey. J Infect Dis 209(6):837–844
Thomas P, Bhatia T, Gauba D, Wood J, Long C, Prasad K, Dickerson FB, Gur RE, Gur RC, Yolken RH, Nimgaonkar VL, Deshpande SN (2013) Exposure to herpes simplex virus, type 1 and reduced cognitive function. J Psychiatr Res 47(11):1680–1685
Vanyukov MM, Nimgaonkar VL, Kirisci L, Kirillova GP, Reynolds MD, Prasad K, Tarter RE, Yolken RH (2017) Association of cognitive function and liability to addiction with childhood herpesvirus infections: a prospective cohort study-ERRATUM. Dev Psychopathol:1–2
Watkins CC, Treisman GJ (2015) Cognitive impairment in patients with AIDS – prevalence and severity. HIV AIDS (Auckl) 7:35–47
Watson AM, Prasad KM, Klei L, Wood JA, Yolken RH, Gur RC, Bradford LD, Calkins ME, Richard J, Edwards N, Savage RM, Allen TB, Kwentus J, McEvoy JP, Santos AB, Wiener HW, Go RC, Perry RT, Nasrallah HA, Gur RE, Devlin B, Nimgaonkar VL (2013) Persistent infection with neurotropic herpes viruses and cognitive impairment. Psychol Med 43(5):1023–1031
Wilhelmus KR, Beck RW, Moke PS, Dawson CR, Barron BA, Jones DB, Kaufman HE, Kurinij N, Stulting D, Sugar J, Cohen JA, Hyndiuk RA, Asbell PA (1998) Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. N Engl J Med 339(5):300–306
Wright CB, Gardener H, Dong C, Yoshita M, DeCarli C, Sacco RL, Stern Y, Elkind MS (2015) Infectious burden and cognitive decline in the Northern Manhattan Study. J Am Geriatr Soc 63(8):1540–1545
Yarlagadda A, Alfson E, Clayton AH (2009) The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry (Edgmont) 6(11):18–22
Yolken RH, Torrey EF, Lieberman JA, Yang S, Dickerson FB (2011) Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. Schizophr Res 128(1-3):61–65
Zhu CW, Sano M, Ferris SH, Whitehouse PJ, Patterson MB, Aisen PS (2013) Health-related resource use and costs in elderly adults with and without mild cognitive impairment. J Am Geriatr Soc 61(3):396–402
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Nimgaonkar, V.L., Bhatia, T., Mansour, A., Wesesky, M.A., Deshpande, S. (2019). Herpes Simplex Virus Type-1 Infection: Associations with Inflammation and Cognitive Aging in Relation to Schizophrenia. In: Khandaker, G., Meyer, U., Jones, P. (eds) Neuroinflammation and Schizophrenia. Current Topics in Behavioral Neurosciences, vol 44. Springer, Cham. https://doi.org/10.1007/7854_2018_86
Download citation
DOI: https://doi.org/10.1007/7854_2018_86
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-39140-9
Online ISBN: 978-3-030-39141-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)